Haemonetics
(NYSE:HAE)
$95.86
3.26[3.52%]
At close: May 10
$95.86
0[0.00%]
After Hours: 4:00PM EDT
Q4 2024 Earnings were released on Thu May 9th, before the market open
The most recent conference call was at 8:00 AM, 2 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
50%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
40
0100

Haemonetics Stock (NYSE:HAE), Quotes and News Summary

Haemonetics Stock (NYSE: HAE) stock price, news, charts, stock research, profile.

Open$94.240
Close$95.860
Volume / Avg.445.067K / 486.325K
Day Range92.570 - 96.380
52 Wk Range70.740 - 97.125
Market Cap$4.868B
P/E Ratio37.642
Dividend Yield-
ExchangeNYSE
RSI
71
Short Interest
6.71%
Days to Cover5.99

Recent News

Haemonetics Q4 Earnings Exceed Expectations On Volume And Price Benefits
Nabaparna Bhattacharya
Alphabet To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Wednesday
Loop Capital boosted the price target for Alphabet Inc. (NASDAQ: GOOGL) from $120 to $125. Loop Capital analyst Rob Sanderson maintained a Buy rating. Alphabet shares fell 3.7% to $103.70 in pre-market trading.
Lisa Levin
Analysts Take Bullish Stance On Haemonetics, Cites Plasma Momentum As Catalyst
Vandana Singh
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Feb
1
Apr
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HAE
SOLV

FAQ

Q

How do I buy Haemonetics (HAE) stock?

A

You can purchase shares of Haemonetics (NYSE: HAE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Haemonetics's (HAE) competitors?

A

Other companies in Haemonetics’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).

Q

What is the target price for Haemonetics (HAE) stock?

A

The latest price target for Haemonetics (NYSE: HAE) was reported by JMP Securities on Friday, May 10, 2024. The analyst firm set a price target for 125.00 expecting HAE to rise to within 12 months (a possible 30.40% upside). 11 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Haemonetics (HAE)?

A

The stock price for Haemonetics (NYSE: HAE) is $95.86 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Haemonetics (HAE) pay a dividend?

A

There are no upcoming dividends for Haemonetics.

Q

When is Haemonetics (NYSE:HAE) reporting earnings?

A

Haemonetics’s Q1 earnings are confirmed for Tuesday, August 6, 2024.

Q

Is Haemonetics (HAE) going to split?

A

There is no upcoming split for Haemonetics.

Q

What sector and industry does Haemonetics (HAE) operate in?

A

Haemonetics is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.

People Also Watch